NewslettersCell Therapy NewsVyriad Announces Strategic Collaboration with Novartis to Develop In Vivo CAR-T Cell TherapiesBy Jamie Kang - November 25, 20240532Vyriad, Inc. announced a strategic collaboration with Novartis to discover and develop in vivo CAR T-cell therapies.[Vyriad, Inc.]Press Release